193 related articles for article (PubMed ID: 32888265)
1. From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides.
Azevedo-Barbosa H; Dias DF; Franco LL; Hawkes JA; Carvalho DT
Mini Rev Med Chem; 2020; 20(19):2052-2066. PubMed ID: 32888265
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents.
Shah SS; Rivera G; Ashfaq M
Mini Rev Med Chem; 2013 Jan; 13(1):70-86. PubMed ID: 22625411
[TBL] [Abstract][Full Text] [Related]
3. Anticancer and antiviral sulfonamides.
Scozzafava A; Owa T; Mastrolorenzo A; Supuran CT
Curr Med Chem; 2003 Jun; 10(11):925-53. PubMed ID: 12678681
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review.
Kumar Verma S; Verma R; Xue F; Kumar Thakur P; Girish YR; Rakesh KP
Bioorg Chem; 2020 Dec; 105():104400. PubMed ID: 33128966
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Properties of some New Lead Sulphonamide and Carboxamide Scaffolds Bearing Coumarin Moieties.
Eze CC; Ezeokonkwo MA; Ezema BE; Onoabedje AE; Ugwu DI
Mini Rev Med Chem; 2021; 21(11):1270-1287. PubMed ID: 32744970
[TBL] [Abstract][Full Text] [Related]
6. Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria.
Swain SS; Paidesetty SK; Padhy RN
Drug Dev Res; 2021 Apr; 82(2):149-166. PubMed ID: 33025605
[TBL] [Abstract][Full Text] [Related]
7. Sulfonamide derivatives as multi-target agents for complex diseases.
Apaydın S; Török M
Bioorg Med Chem Lett; 2019 Aug; 29(16):2042-2050. PubMed ID: 31272793
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation.
Benediktsdottir A; Lu L; Cao S; Zamaratski E; Karlén A; Mowbray SL; Hughes D; Sandström A
Eur J Med Chem; 2021 Nov; 224():113699. PubMed ID: 34352713
[TBL] [Abstract][Full Text] [Related]
9. Isoleucine with secondary sulfonamide functionality as anticancer, antibacterial and antifungal agents.
Devi K; Awasthi P
J Biomol Struct Dyn; 2022 Sep; 40(15):7052-7069. PubMed ID: 33704017
[TBL] [Abstract][Full Text] [Related]
10. Sulfonamides with Heterocyclic Periphery as Antiviral Agents.
Moskalik MY
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615245
[TBL] [Abstract][Full Text] [Related]
11. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and Antibacterial Activity of Sulfonamides Derived from Carvacrol: A Structure-Activity Relationship Study.
de Oliveira AS; de Souza LFS; Nunes RJ; Johann S; Palomino-Salcedo DL; Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(3):173-181. PubMed ID: 31775599
[TBL] [Abstract][Full Text] [Related]
13. The sulfonamide group as a structural alert: A distorted story?
Smith DA; Jones RM
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):72-9. PubMed ID: 18175269
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives.
Konda S; Raparthi S; Bhaskar K; Munaganti RK; Guguloth V; Nagarapu L; Akkewar DM
Bioorg Med Chem Lett; 2015 Apr; 25(7):1643-6. PubMed ID: 25754493
[TBL] [Abstract][Full Text] [Related]
15. Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.
Kawai T; Kazuhiko I; Takaya N; Yamaguchi Y; Kishii R; Kohno Y; Kurasaki H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1045-1049. PubMed ID: 28082037
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties.
Karaman N; Adil Zainel R; Kapkaç HA; Karaca Gençer H; Ilgın S; Karaduman AB; Karaküçük-İyidoğan A; Oruç-Emre EE; Koçyiğit-Kaymakçıoğlu B
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800057. PubMed ID: 30079557
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives.
Lin H; Bruhn DF; Maddox MM; Singh AP; Lee RE; Sun D
Bioorg Med Chem Lett; 2016 Aug; 26(16):4070-6. PubMed ID: 27406794
[TBL] [Abstract][Full Text] [Related]
18. Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies.
Camoutsis C; Geronikaki A; Ciric A; Soković M; Zoumpoulakis P; Zervou M
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):160-7. PubMed ID: 20118573
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, identification, and antibacterial activity of new sulfonamide nanoparticles.
Nabipour H
IEEE Trans Nanobioscience; 2012 Sep; 11(3):296-303. PubMed ID: 22929481
[TBL] [Abstract][Full Text] [Related]
20. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.
Metwally NH; Mohamed MS
Bioorg Chem; 2020 Jun; 99():103438. PubMed ID: 31796216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
